New Delhi: Amid growing cases of corona virus, American company Johnson & Johnson said its first batch of covid-19 vaccine may be available in January. Recently the company suffered side effects during the trial.
Raxandra Draghia Akali, head of Johnson & Johnson Company, said, “The company may launch its first batch of covid-19 vaccines for emergency use in January.
It is known that Johnson & Johnson halted the trial after side effects were revealed. It is being told that the test may resume soon. The company had said that under this, vaccines will be tested on 60 thousand people in the US, South Africa, Brazil, Chile, Colombia, Mexico and Peru.
Oxford University and AstraZeneca’s vaccine was at the forefront of the vaccine race, but Phase III trials had to be halted on September 6 when conditions worsened after some volunteers had taken the Covishield vaccine. However, there have been resumes in Britain and India. However, the US or other countries have not yet approved it again.
